In RTOG 0822, a phase II study looking at preoperative chemoradiotherapy utilizing IMRT for patients with cT3-T4 rectal cancer, was the rate of GI toxicity decreased?
In RTOG 0822, a phase II study looking at preoperative chemoradiotherapy utilizing IMRT for patients with cT3-T4 rectal cancer, was the rate of GI toxicity decreased?